JPS6244558B2 - - Google Patents
Info
- Publication number
- JPS6244558B2 JPS6244558B2 JP53149028A JP14902878A JPS6244558B2 JP S6244558 B2 JPS6244558 B2 JP S6244558B2 JP 53149028 A JP53149028 A JP 53149028A JP 14902878 A JP14902878 A JP 14902878A JP S6244558 B2 JPS6244558 B2 JP S6244558B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- difluoro
- group
- ether
- above formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 20
- -1 24,24-difluoro-25-hydroxycholestenes Chemical class 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 description 31
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 18
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 12
- 229910052717 sulfur Inorganic materials 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 125000006239 protecting group Chemical group 0.000 description 9
- 229910052786 argon Inorganic materials 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 238000000921 elemental analysis Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 125000002252 acyl group Chemical group 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 125000001033 ether group Chemical group 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 229910004298 SiO 2 Inorganic materials 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- LRNVEDCUBISUTC-OWRPZGOZSA-N 24,24-difluoro-25-hydroxyvitamin D3 Chemical compound C1(/[C@@H]2CCC([C@]2(CCC1)C)[C@@H](CCC(F)(F)C(C)(C)O)C)=C\C=C1\C[C@H](O)CCC1=C LRNVEDCUBISUTC-OWRPZGOZSA-N 0.000 description 2
- OMIHGPLIXGGMJB-UHFFFAOYSA-N 7-oxabicyclo[4.1.0]hepta-1,3,5-triene Chemical compound C1=CC=C2OC2=C1 OMIHGPLIXGGMJB-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 238000003747 Grignard reaction Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 239000012259 ether extract Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000012746 preparative thin layer chromatography Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- DTHLYGJVQJMKSB-BMXWGISTSA-N (6R)-6-[(8R,9S,10S,13R,14S,17R)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylhept-4-en-3-one Chemical class C[C@H](C=CC(=O)C(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C DTHLYGJVQJMKSB-BMXWGISTSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001274216 Naso Species 0.000 description 1
- YZODIHNPYMHCMD-LDHZKLTISA-N OC=C(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C Chemical class OC=C(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4CCCC[C@]4(C)[C@H]3CC[C@]12C YZODIHNPYMHCMD-LDHZKLTISA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 108700039708 galantide Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- OTCKOJUMXQWKQG-UHFFFAOYSA-L magnesium bromide Chemical compound [Mg+2].[Br-].[Br-] OTCKOJUMXQWKQG-UHFFFAOYSA-L 0.000 description 1
- 229910001623 magnesium bromide Inorganic materials 0.000 description 1
- CCERQOYLJJULMD-UHFFFAOYSA-M magnesium;carbanide;chloride Chemical compound [CH3-].[Mg+2].[Cl-] CCERQOYLJJULMD-UHFFFAOYSA-M 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- CASUWPDYGGAUQV-UHFFFAOYSA-M potassium;methanol;hydroxide Chemical compound [OH-].[K+].OC CASUWPDYGGAUQV-UHFFFAOYSA-M 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000006894 reductive elimination reaction Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- MRTAVLDNYYEJHK-UHFFFAOYSA-M sodium;2-chloro-2,2-difluoroacetate Chemical compound [Na+].[O-]C(=O)C(F)(F)Cl MRTAVLDNYYEJHK-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は、新規化合物である24,24―ジフルオ
ロ―25―ヒドロキシコレステン類に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to novel compounds, 24,24-difluoro-25-hydroxycholestenes.
本発明で提供される24,24―ジフルオロ―25―
ヒドロキシコレステン類は、下記式〔〕で表わ
される。 24,24-difluoro-25- provided by the present invention
Hydroxycholestenes are represented by the following formula [].
〔式中、Rは水素原子または水酸基の保護基で
ある。また、〓は、単結合又は二重結合を表わ
す。〕
上記式〔〕で表わされる化合物は、24,24―
ジフルオロ―25―ヒドロキシビタミンD3に導か
れうる中間体であり有用な化合物である。すなわ
ち、24,24―ジフルオロ―25―ヒドロキシビタミ
ンD3は、本発明者が別途提案した通り、ビタミ
ンD3系列化合物と同種の薬理作用を示すものと
して充分に期待される化合物である。 [In the formula, R is a hydrogen atom or a hydroxyl group-protecting group. Moreover, 〓 represents a single bond or a double bond. ] The compound represented by the above formula [ ] is 24,24-
It is an intermediate and a useful compound that can be derived from difluoro-25-hydroxyvitamin D3 . That is, 24,24-difluoro-25-hydroxyvitamin D 3 is a compound that is fully expected to exhibit the same type of pharmacological action as the vitamin D 3 series compounds, as separately proposed by the present inventor.
それ故、上記式〔〕中における水酸基の保護
基としては、相当する5―エン又は5,7―ジエ
ンより製造するビタミンD3の公知の製造方法に
おいて、該5―エン又は該5,7―ジエンの水酸
基の保護基として用いられ得る、通常の加水分解
反応又は還元的脱離反応により除去しうるもので
あれば如何なるものでもよい。 Therefore, as the protecting group for the hydroxyl group in the above formula [], in the known production method of vitamin D 3 produced from the corresponding 5-ene or 5,7-diene, the 5-ene or the 5,7- Any group that can be used as a protecting group for the hydroxyl group of a diene and can be removed by a conventional hydrolysis reaction or reductive elimination reaction may be used.
かかる保護基は、例えば、米国特許第4022891
号 明細書に記載されている。 Such protecting groups are described, for example, in US Pat. No. 4,022,891.
No. stated in the specification.
これらのうち、特に好ましい保護基は、アセチ
ル基、ベンゾイル基、ピバロイル基等のアシル基
であり、また、エトキシエチル基、メトキシメチ
ル基、テトラヒドロピラニル基、トリメチルシリ
ル基、t―ブチルジメチルシリル基の如き水酸基
の酸素原子と結合してエーテル基を形成するもの
である。 Among these, particularly preferred protecting groups are acyl groups such as acetyl, benzoyl, and pivaloyl groups, and ethoxyethyl, methoxymethyl, tetrahydropyranyl, trimethylsilyl, and t-butyldimethylsilyl groups. It combines with the oxygen atom of a hydroxyl group to form an ether group.
しかして、上記式〔〕で表わされる24,24―
ジフルオロ―25―ヒドロキシコレステン類は、B
環に存在する二重結合の数により、下記式〔〕
―aおよび式〔〕―bで表わされる2つの化合
物群に分けられる。 Therefore, 24, 24- expressed by the above formula []
Difluoro-25-hydroxycholestenes are B
Depending on the number of double bonds present in the ring, the following formula []
It is divided into two groups of compounds represented by the formula -a and formula []-b.
すなわち、1つは下記式〔〕―a、
〔式中、Rの定義は、上記に同じである。〕
で表わされる24,24―ジフルオロ―25―ヒドロキ
シコレスタ―5―エン又はその水酸基保護誘導体
であり、他の1つは、下記式〔〕―b、
〔式中、Rの定義は、上記に同じである。〕
で表わされる24,24―ジフルオロ―25―ヒドロキ
シコレスタ―5,7―ジエン又はその水酸基保護
誘導体である。 That is, one is the following formula []-a, [In the formula, the definition of R is the same as above. ] 24,24-difluoro-25-hydroxycholest-5-ene or its hydroxy protected derivative represented by the following formula []-b, [In the formula, the definition of R is the same as above. ] 24,24-difluoro-25-hydroxycholester-5,7-diene or its hydroxyl protected derivative.
本発明の24,24―ジフルオロ―25―ヒドロキシ
コレステン類を、上記2つの群に分けて記載すれ
ば、次のとおりである。 The 24,24-difluoro-25-hydroxycholestenes of the present invention can be divided into the above two groups and described as follows.
式〔〕―aに属する化合物としては、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5―エン、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5―エン―3β―アセテート、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5―エン―3β―ベンゾエート、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5―エン―3β―テトラヒドロピラニルエーテ
ル、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5―エン―3β―トリメチルシリルエーテル、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5―エン―3β―t―ブチルジメチルエーテル
等をあげることができる。 Compounds belonging to formula []-a include 24,24-difluoro-25-hydroxycholest-5-ene, 24,24-difluoro-25-hydroxycholest-5-ene-3β-acetate, 24,24 -difluoro-25-hydroxycholest-5-ene-3β-benzoate, 24,24-difluoro-25-hydroxycholest-5-ene-3β-tetrahydropyranyl ether, 24,24-difluoro-25-hydroxycholesta -5-ene-3β-trimethylsilyl ether, 24,24-difluoro-25-hydroxycholest-5-ene-3β-t-butyl dimethyl ether, and the like.
また、式〔〕―bに属する化合物としては、
24,24―ジフルオロ―25―ヒドロキシコレスタ―
5,7―ジエン、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5,7―ジエン―3β―アセテート、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5,7―ジエン―3β―ベンゾエート、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5,7―ジエン―3β―テトラヒドロピラニル
エーテル、
24,24―ジフルオロ―25―ヒドロキシコレスタ
―5,7―ジエン―3β―t―ブチルジメチルシ
リルエーテル、等をあげることができる。 In addition, as compounds belonging to formula []-b,
24,24-difluoro-25-hydroxycholester
5,7-diene, 24,24-difluoro-25-hydroxycholester-5,7-diene-3β-acetate, 24,24-difluoro-25-hydroxycholester-5,7-diene-3β-benzoate, 24,24-difluoro-25-hydroxycholester-5,7-diene-3β-tetrahydropyranyl ether, 24,24-difluoro-25-hydroxycholester-5,7-diene-3β-t-butyldimethylsilyl ether , etc. can be given.
上記式〔〕(式〔〕―aおよび式〔〕―
bを含む)で表わされる24,24―ジフルオロ―25
―ヒドロキシコレステン類下記の如き方法で製造
される。 The above formula [] (formula []-a and formula []-
24,24-difluoro-25 represented by
-Hydroxycholestenes are produced by the following method.
すなわち、下記式〔〕、
〔式中、Rおよび〓の定義は、前記式〔〕の
場合と同じである。〕
で表わされる3β―ヒドロキシ―24,24―ジフル
オロ―27―ノルコレステン―25―オン類を、それ
自体公知の方法で非プロトン性不活性溶媒中でメ
チルマグネシウムハライド、例えば、メチルマグ
ネシウムアイオダイド、メチルマグネシウムブロ
マイド,メチルマグネシウムクロライド等と反応
せしめる。 That is, the following formula [], [In the formula, the definitions of R and 〓 are the same as in the case of the above formula []. ] 3β-hydroxy-24,24-difluoro-27-norcholesten-25-ones represented by methylmagnesium halide, e.g. methylmagnesium iodide, methyl React with magnesium bromide, methylmagnesium chloride, etc.
上記式〔〕で表わされる出発物質は、目的物
を表わす上記式〔〕が上記式〔〕―aおよび
〔〕―bに分けて表現されるように、これに対
応して、2つの化合物群、すなわち、下記式
〔〕―a、
〔式中、Rの定義は前記に同じである。〕
で表わされる3β―ヒドロキシ―24,24―ジフル
オロ―27―ノルコレスタ―5―エン―25―オン又
はその水酸基保護誘導体および下記式〔〕―
b、
〔式中、Rの定義は、前記に同じである。〕
で表わされる3β―ヒドロキシ―24,24―ジフル
オロ―27―ノルコレスタ―5,7―ジエン―25―
オン又はその水酸基保護誘導体である。 The starting material represented by the above formula [] corresponds to two compound groups, such that the above formula [] representing the target product is divided into the above formulas []-a and []-b. , that is, the following formula []-a, [In the formula, the definition of R is the same as above. ] 3β-hydroxy-24,24-difluoro-27-norcholest-5-en-25-one or its hydroxy protected derivative and the following formula []-
b, [In the formula, the definition of R is the same as above. ] 3β-hydroxy-24,24-difluoro-27-norcholester-5,7-diene-25-
ion or its hydroxyl-protected derivative.
上記式〔〕(式〔〕―a又は式〔〕―b
を含む)で表わされる化合物は、基Rの定義に従
つて、上記式〔〕で表わされる化合物の具体例
からも自ずと明らかである。 The above formula [] (formula []-a or formula []-b)
In accordance with the definition of the group R, the compounds represented by the above formula [] are also obvious from the specific examples of the compounds represented by the above formula [].
また、本発明の化合物の製造方法は、それ自体
公知の反応として知られているグリニアー
(Grignard)反応であり、非プロトン性不活性溶
媒、好適には無水ジエチルエーテル中において、
氷冷下に行なわれる。一方の出発物質は上記式
〔〕で表わされる3β―ヒドロキシ―24,24―
ジフルオロ―27―ノルコレステン―25―オン類で
あり、これに対し他方の出発物質であるメチルマ
グネシウムアイオダイドを過剰に加えて一般には
実施される。 Furthermore, the method for producing the compound of the present invention is the Grignard reaction, which is known as a reaction known per se, in an aprotic inert solvent, preferably anhydrous diethyl ether.
It is carried out under ice cooling. One of the starting materials is 3β-hydroxy-24,24- represented by the above formula []
It is generally carried out by adding an excess of methylmagnesium iodide, which is the other starting material, to difluoro-27-norcholesten-25-ones.
この方法によれば、上記グリニアー反応の結
果、Rが水素原子又はアシル基である上記式
〔〕で表わされる化合物を用いた場合には、式
〔〕においてRが水素原子である目的物が得ら
れ、また、Rが水酸基の酸素原子と結合してエー
テル基を形成している基である上記式〔〕で表
わされる出発物質を用いた場合には、式〔〕に
おいてもRがそのまま変化しない式〔〕で表わ
される目的物が得られる。 According to this method, as a result of the Grignard reaction, when a compound represented by the above formula [] in which R is a hydrogen atom or an acyl group is used, a target product in which R is a hydrogen atom in the formula [] can be obtained. In addition, when using a starting material represented by the above formula [] in which R is a group that combines with the oxygen atom of a hydroxyl group to form an ether group, R does not change as it is in formula []. The object expressed by the formula [] is obtained.
かくして、得られた上記式〔〕で表わされる
目的物は、式〔〕において基Rが水素原子又は
エーテル基を形成する基のものである。 The thus obtained target product represented by the above formula [] is a group in which the group R forms a hydrogen atom or an ether group.
それ故、基Rが水素原子の化合物すなわち、遊
離の水酸基を持つ上記式〔〕の化合物を、次い
で、それ自体公知である水酸基の保護反応に付す
ことにより、基Rが水酸基の保護基である式
〔〕で表わされる化合物を得ることができる。 Therefore, a compound in which the group R is a hydrogen atom, that is, a compound of the above formula [] having a free hydroxyl group, is then subjected to a hydroxyl group-protecting reaction which is known per se, so that the group R is a hydroxyl-protecting group. A compound represented by the formula [] can be obtained.
また、基Rが水酸基の保護基である式〔〕の
化合物をそれ自体公知の保護基の脱離反応に付す
ことにより、基Rが水素原子である式〔〕で表
わされる化合物を得ることができる。 Furthermore, by subjecting a compound of formula [] in which group R is a hydroxyl group-protecting group to a protective group elimination reaction known per se, a compound represented by formula [] in which group R is a hydrogen atom can be obtained. can.
上記水酸基の保護反応は、例えば、アシル基で
保護する場合には、塩基性化合物(例えば、ピリ
ジンなど)の存在下に、酸無水物あるいはアシル
ハライドで処理することにより行うことができ、
また、エーテル基で保護する場合には、ジヒドロ
ピランあるいはメチルビニルエーテル等で処理す
ぬことにより行うことができる。 The above-mentioned protection reaction of the hydroxyl group can be carried out, for example, when protecting with an acyl group, by treatment with an acid anhydride or an acyl halide in the presence of a basic compound (e.g., pyridine, etc.).
Further, when protecting with an ether group, it can be carried out by treatment with dihydropyran or methyl vinyl ether.
また、水酸基の保護基の脱離反応は、例えば、
保護基がアシル基の場合、アルコール溶媒(エタ
ノール、メタノール等)中においてアルカリ金属
水酸化物(苛性ソーダ、苛性カリ等)で処理する
ことにより行なわれ、また、保護基がエーテル基
の場合には、リチウムアルミニウムハイドライド
の如き還元剤で還元処理することにより行なわれ
る。 In addition, the elimination reaction of the protecting group of the hydroxyl group is, for example,
When the protecting group is an acyl group, this is carried out by treatment with an alkali metal hydroxide (caustic soda, caustic potash, etc.) in an alcohol solvent (ethanol, methanol, etc.), and when the protecting group is an ether group, lithium This is carried out by reduction treatment with a reducing agent such as aluminum hydride.
なお、本発明の化合物の25位の水酸基も、必要
に応じて、前記と同様な方法で保したり保護基を
はずしたりすることができる。 Note that the hydroxyl group at position 25 of the compound of the present invention can also be retained or the protective group removed by the same method as described above, if necessary.
上記の如く、遊離の水酸基又は水酸基アシル基
により保護された上記式〔〕で表わされる出発
物質を用いた場合には、メチルマグネシウムハラ
イドとの反応により、遊離の水酸基を有する式
〔〕の化合物が得られるが、この場合には、そ
のまま反応系より分離することもできるが、反応
系内において引き続き上記の水酸基保護反応に付
し、水酸基が保護された上記式〔〕の化合物と
して反応系内より分離するのが便利である。 As mentioned above, when a starting material represented by the above formula [] protected by a free hydroxyl group or a hydroxyl acyl group is used, a compound of the formula [] having a free hydroxyl group is formed by reaction with methylmagnesium halide. In this case, it can be separated from the reaction system as it is, but it can be separated from the reaction system as a compound of the above formula [] with a protected hydroxyl group by subsequently subjecting it to the above hydroxyl group protection reaction in the reaction system. It is convenient to separate them.
反応混合物より、上記式〔〕の本発明の目的
物を単離するには、例えば、カラムクロマトグラ
フイー、薄層クロマトグラフイー,高速液体クロ
マトグラフイーあるいは再結晶等により行なえば
よい。 The target product of the present invention represented by the above formula [] can be isolated from the reaction mixture by, for example, column chromatography, thin layer chromatography, high performance liquid chromatography, recrystallization, or the like.
本発明により提供される24,24―ジフルオロ―
25―ヒドロキシコレステノン類は新規化合物であ
り、それ自体公知の方法により24,24―ジフルオ
ロ―25―ヒドロキシビタミンD3又はその水酸基
保護誘導体に容易に変換することができる。 24,24-difluoro- provided by the present invention
25-Hydroxycholestenones are new compounds and can be easily converted into 24,24-difluoro-25-hydroxyvitamin D 3 or its hydroxy-protected derivatives by methods known per se.
以下、実施例をあげ本発明を詳述するが、本発
明において用いられる上記式〔〕で表わされる
3β―ヒドロキシ―24,24―ジフルオロ―27―ノ
ルコレステン―25―オン類又はその水酸基保護誘
導体も、本発明者が知る限り新規化合物であり、
それ故、まず、参考例として、上記式〔〕で表
わされる化合物の合成法を記述する。 Hereinafter, the present invention will be described in detail with reference to Examples, but the 3β-hydroxy-24,24-difluoro-27-norcholesten-25-ones represented by the above formula [] or its hydroxyl-protected derivatives used in the present invention may also be used. , is a new compound as far as the inventors know,
Therefore, first, as a reference example, a method for synthesizing the compound represented by the above formula [] will be described.
なお、実施例中には、上記式〔〕―aで表わ
される化合物から上記式〔〕―bで表わされる
化合物を製造する例を記載した。上記式〔〕―
bで表わされる化合物は、必ずしもこのような方
法によつて製造する必要はなく、上記式〔〕―
aで表わされる化合物から上記式〔〕―bで表
わされる化合物を製造し、この化合物に対し本発
明方法を実施することにより製造しうることはも
ちろんである。 In the Examples, an example was described in which a compound represented by the above formula []-b was produced from a compound represented by the above formula []-a. The above formula [] -
The compound represented by b does not necessarily need to be produced by such a method, and the compound represented by the above formula []--
Of course, the compound represented by the above formula []-b can be produced from the compound represented by a, and the method of the present invention can be performed on this compound.
参考例 1
(1) 3β―アセトキシ―26,27―ジノルコレスタ
―5―エン―24―オン
mp.;148〜151℃
nmr(CDCl3,TMS,δ(ppm));
5.36(1H,m,C―6),4.60(1H,m,C
―3),2.12(3H,S,C―25),2.02
(3H,S,C―3アセチル)、
mass(m/e);
354(M―60),339(M―60―15),296,
255,215,213.
ir(in CH2Cl2);1730cm-1
元素分析(C27H42O3);
計算値,C;78.21,H;10.21
実測値,C;78.12,H;10.36
の2.730g(6.58mmol)および220mgのパラト
ルエンスルホン酸を無水酢酸(50ml)中、7時
間加熱還流後、約20mlの無水酢酸を常圧留去し
た。反応混合物を冷却後、0.5%―NaOHにあ
け、エーテル―ヘキサン(2:1)で抽出し
た。有機層を水洗、乾燥(無水硫酸ナトリウ
ム)後、シリカゲルカラムクロマトにより分離
精製した(担体,SiO2,220g)。ベンゼン―
エーテル(100:1)溶出部分より3β,24―
ジアセトキシ―26,27―ジノルコレスタ―5,
23―ジエンを得た。収量2.162g(収率72%)
m.p.;109〜11℃(メタノールより再結)、
n.m.r(CDCl3,TMS,δ);
5.40(1H,m,C―6),5.02(1H,m,C
―23),4.60(1H,m,C―3),2.14
(3H,S,C―240AC),2.03(3H,S,C
―30AC),1.90(C―25);
mass(m/e);
396(M―60),354(M―60―42),283,
253,
i.r.(in CH2Cl2);1750,1735cm-1
元素分析(C29H44O4);
計算値,C;76.27,H;9.71
実測値,C;76.15,H;9.77
又、ベンゼン―エーテル(20:1)溶出部分よ
り、原料を313mg回収した。Reference example 1 (1) 3β-acetoxy-26,27-dinorcholest-5-en-24-one mp.; 148-151℃ nmr (CDCl 3 , TMS, δ (ppm)); 5.36 (1H, m, C -6), 4.60 (1H, m, C
-3), 2.12 (3H, S, C-25), 2.02
(3H, S, C-3 acetyl), mass (m/e); 354 (M-60), 339 (M-60-15), 296,
255, 215, 213. ir (in CH 2 Cl 2 ); 1730 cm -1 elemental analysis (C 27 H 42 O 3 ); Calculated value, C; 78.21, H; 10.21 Actual value, C; 78.12, H; 10.36 After heating and refluxing 2.730 g (6.58 mmol) and 220 mg of para-toluenesulfonic acid in acetic anhydride (50 ml) for 7 hours, about 20 ml of acetic anhydride was distilled off at normal pressure. After cooling the reaction mixture, it was poured into 0.5%-NaOH and extracted with ether-hexane (2:1). The organic layer was washed with water, dried (anhydrous sodium sulfate), and then separated and purified by silica gel column chromatography (carrier, SiO 2 , 220 g). benzene-
From the ether (100:1) elution part, 3β,24-
Diacetoxy-26,27-dinorcholester-5,
23-Diene was obtained. Yield 2.162g (yield 72%) mp: 109-11℃ (reconsolidated from methanol), nmr (CDCl 3 , TMS, δ); 5.40 (1H, m, C-6), 5.02 (1H, m, C
-23), 4.60 (1H, m, C-3), 2.14
(3H, S, C-240AC), 2.03 (3H, S, C
-30AC), 1.90 (C-25); mass (m/e); 396 (M-60), 354 (M-60-42), 283,
253, ir (in CH 2 Cl 2 ); 1750, 1735 cm -1 elemental analysis (C 29 H 44 O 4 ); Calculated value, C; 76.27, H; 9.71 Actual value, C; 76.15, H; 9.77 Also, benzene - 313 mg of raw material was recovered from the ether (20:1) eluted portion.
(2) アルゴン気流中、上記(1)の生成物2.162g
(4.74mmol)をジグライム15mlに溶解し、170
〜185℃に加熱した。クロロジフルオロ酢酸ナ
トリウム(10.84g)のジグライム溶液(35
ml)をゆつくり滴下した(約15分)。滴下終了
後、20分間加熱還流した。冷後、反応混合物を
水(200ml)、エーテル(100ml)にあけ、不溶
物をロ別後、ロ液をヘキサン(300ml)で抽
出、水洗(200ml×2)、乾燥(無水硫酸ナトリ
ウム)した。シリカゲムカラムクロマトグラフ
で分離、精製し(SiO2,150g)、ベンゼン溶
出部分より、得られた粗結晶をメタノールで再
結晶して、下記式で表わされる化合物819mgを
得た。(2) 2.162 g of the product of (1) above in an argon stream
(4.74 mmol) in 15 ml of diglyme, 170
Heated to ~185°C. Sodium chlorodifluoroacetate (10.84g) in diglyme solution (35g)
ml) was slowly added dropwise (about 15 minutes). After the dropwise addition was completed, the mixture was heated under reflux for 20 minutes. After cooling, the reaction mixture was poured into water (200 ml) and ether (100 ml), and after filtering out insoluble matter, the filtrate was extracted with hexane (300 ml), washed with water (200 ml x 2), and dried (anhydrous sodium sulfate). The product was separated and purified by silica gel column chromatography (SiO 2 , 150 g), and the obtained crude crystals were recrystallized from methanol from the benzene eluted portion to obtain 819 mg of a compound represented by the following formula.
m.p;112〜115℃
nmr(CDCl3,TMS,δ(ppm));
5.38(1H,m,C―6),4.60(1H,m,C
―3),2.05(3H,S,C―240アセチル),
2.02(3H,S,C―30アセチル)、
mass(m/e);
446(M―60),431(M―60―15),
404(M―60―42),384(M―60―42―20)、
i.r.(in CH2Cl2);1760,1730cm-1、
元素分析(C30H44O4F2);
計算値,C;71.11,H;8.75,F;7.50
実測値,C;71.26,H;8.84,F;7.50、
(3) 上記(2)の生成物394mg(0.78mmol)を、テト
ラヒドロフラン(THF)15mlに溶解し、水酸
化リチウム1水和物(LiOH・H2O 140mg)の
水(10ml)―メタノール(4ml)溶液を加え、
室温で2時間半撹拌した後、水を加え、エーテ
ルで抽出した。エーテル抽出液を水洗乾燥(無
水NaSO4)、減圧下濃縮乾燥後、残渣を無水塩
化メチレン(10ml)、ピリジン(2.5ml)および
無水酢酸(2.5ml)に溶解して、室温で24時間
撹拌した。減圧下濃縮後残渣をエーテルに溶解
し、希塩酸、5%―NaHCO3水溶液および食塩
水で洗浄後、乾燥(無水Na2SO4)した。シリカ
ゲルカラムクロマトグラフにより、分離.精製
した(SiO2,200g)。ベンゼン溶出部分よ
り、3β―アセトキシ―24,24―ジフルオロ―
27―ノルコレスタ―5―エン―25―オンを得
た。収量43mg。 mp; 112-115℃ nmr (CDCl 3 , TMS, δ (ppm)); 5.38 (1H, m, C-6), 4.60 (1H, m, C
-3), 2.05 (3H, S, C-240 acetyl),
2.02 (3H, S, C-30 acetyl), mass (m/e); 446 (M-60), 431 (M-60-15), 404 (M-60-42), 384 (M-60- 42-20), ir (in CH 2 Cl 2 ); 1760, 1730 cm -1 , elemental analysis (C 30 H 44 O 4 F 2 ); calculated value, C; 71.11, H; 8.75, F; 7.50 actual value, C; 71.26, H; 8.84, F; 7.50, (3) 394 mg (0.78 mmol) of the product from (2) above was dissolved in 15 ml of tetrahydrofuran (THF), and lithium hydroxide monohydrate (LiOH・H 2 Add a water (10 ml)-methanol (4 ml) solution of O (140 mg),
After stirring at room temperature for 2.5 hours, water was added and extracted with ether. The ether extract was washed with water and dried (anhydrous NaSO 4 ), concentrated and dried under reduced pressure, and the residue was dissolved in anhydrous methylene chloride (10 ml), pyridine (2.5 ml) and acetic anhydride (2.5 ml), and the solution was stirred at room temperature for 24 hours. . After concentration under reduced pressure, the residue was dissolved in ether, washed with dilute hydrochloric acid, 5% aqueous NaHCO 3 solution and brine, and dried (anhydrous Na 2 SO 4 ). Separation by silica gel column chromatography. Purified (SiO 2 , 200g). From the benzene elution part, 3β-acetoxy-24,24-difluoro-
I got 27-norcolester-5-en-25-on. Yield 43mg.
m.p.;135〜136.5℃(n―ヘキサンより再結
晶)、
n.m.r.(CDCl3,TMS,δ);
5.32(1H,m,C―6),4.50(1H,m,C
―3),2.26(3H,t,JHF=1Hz,C―
26),1.96(3H,S,C―30AC)、
mass(m/e);
404(M―60),389(M―60―15),296,
283,255
i.r.(KBr);
1750,1730,1255,1040cm-1
さらに、ベンゼン溶出部分より、3β―アセト
キシ―24―フルオロ―27―ノルコレスタ―5.23
(E)―ジエン―25―オン34mgを得た。 mp; 135-136.5°C (recrystallized from n-hexane), nmr ( CDCl3 , TMS, δ); 5.32 (1H, m, C-6), 4.50 (1H, m, C
-3), 2.26 (3H, t, JHF=1Hz, C-
26), 1.96 (3H, S, C-30AC), mass (m/e); 404 (M-60), 389 (M-60-15), 296,
283, 255 ir (KBr); 1750, 1730, 1255, 1040 cm -1 Furthermore, from the benzene elution part, 3β-acetoxy-24-fluoro-27-norcholesta-5.23
34 mg of (E)-diene-25-one was obtained.
m.p.;142〜143℃(メタノールより再結晶)、
n.m.r.(CDCl3,TMS);
5.62(1H,dt,JHF=22Hz,JHH=8Hz,
C―23),5.30(1H,m,C―6),4.52
(1H,m,C―3),2.23(3H,d,J=5
Hz,C―26),1.96(3H,S,C―30AC)
mass(m/e);
384(M―60),369(M―60―15),283,
255,253,213
i.r.(KBr);
1730,1705,1640,1255cm-1
元素分析(C28H41O3F);
計算値,C;75.63,H;9.30,F;4.27
実測値,C;75.35,H;9.52
また、ベンゼン―エーテル(30:1)溶出部分
より、3β―アセトキシ―24―フルオロ―27―
ノルコレスタ―5,23(Z)―ジエン―25―オ
ン234mgを得た。 mp; 142-143℃ (recrystallized from methanol), nmr ( CDCl3 , TMS); 5.62 (1H, dt, JHF=22Hz, JHH=8Hz,
C-23), 5.30 (1H, m, C-6), 4.52
(1H, m, C-3), 2.23 (3H, d, J=5
Hz, C-26), 1.96 (3H, S, C-30AC) mass (m/e); 384 (M-60), 369 (M-60-15), 283,
255, 253, 213 ir (KBr); 1730, 1705, 1640, 1255 cm -1 Elemental analysis (C 28 H 41 O 3 F); Calculated value, C; 75.63, H; 9.30, F; 4.27 Actual value, C; 75.35, H; 9.52 Also, from the benzene-ether (30:1) elution part, 3β-acetoxy-24-fluoro-27-
234 mg of norcholester-5,23(Z)-dien-25-one was obtained.
m.p.;169〜170℃(メタノールより再結晶)、
n.m.r.(CDCl3,TMS);
6.03(1H,dt,JHF=34Hz,JHH=8Hz,
C―23),5.35(1H,m,C―6),4.52
(1H,m,C―3),2.27(3H,d,J=3
Hz,C―26),200(3H,S,C―30AC)
mass(m/e);
384(M―60),369(M―60―15),283,
256,213
i.r.(KBr);
1730,1695,1650,1240cm-1
元素分析(C28H41O3F);
計算値,C;75.63,H;9.30,F;4.27
実測値,C;75.51,H;9.37,F;3.97
実施例 1
アルゴン気流中、上記参考例1の(3)で得られた
3β―アセトキシ―24,24―ジフルオロ―27―ノ
ルコレスタ―5―エン―25―オン70mg
(0.15mmol)を無水エーテル10mlに溶解した。氷
冷、撹拌下、過剰のCH3MgIのエーテル溶液(約
1.8mmol)を加え、15分間撹拌した。反応混合物
に希塩酸を加え、エーテルで抽出した。エーテル
抽出液を水洗、乾燥(MgSO4)後、減圧下濃縮、
乾燥し、残渣(24,24―ジフルオロ―25―ヒドロ
キシコレスタ―5―エンを含む)を無水塩化メチ
レン(5ml)、ピリジン(2ml)および無水酢酸
(2ml)に溶解して、室温で20時間撹拌した。減
圧下濃縮した後、シリカゲルカラムクロマトによ
り分離、精製(SiO2 40g)し、ベンゼン―エー
テル(20:1)溶出部分より、粗結晶を得た。収
量62mg。これをシクロヘキサンとn―ヘキサンの
混合溶媒で再結晶して、3β―アセトキシ―24,
24―ジフルオロコレスタ―5―エン―25―オール
44mgを得た。 mp; 169-170℃ (recrystallized from methanol), nmr ( CDCl3 , TMS); 6.03 (1H, dt, JHF=34Hz, JHH=8Hz,
C-23), 5.35 (1H, m, C-6), 4.52
(1H, m, C-3), 2.27 (3H, d, J=3
Hz, C-26), 200 (3H, S, C-30AC) mass (m/e); 384 (M-60), 369 (M-60-15), 283,
256, 213 ir (KBr); 1730, 1695, 1650, 1240 cm -1 Elemental analysis (C 28 H 41 O 3 F); Calculated value, C; 75.63, H; 9.30, F; 4.27 Actual value, C; 75.51, H; 9.37, F; 3.97 Example 1 In an argon stream, 70 mg of 3β-acetoxy-24,24-difluoro-27-norcholest-5-en-25-one obtained in (3) of Reference Example 1 above.
(0.15 mmol) was dissolved in 10 ml of anhydrous ether. Under ice-cooling and stirring, add excess CH 3 MgI in ether (approx.
1.8 mmol) was added and stirred for 15 minutes. Dilute hydrochloric acid was added to the reaction mixture, and the mixture was extracted with ether. The ether extract was washed with water, dried (MgSO 4 ), concentrated under reduced pressure,
The dried residue (containing 24,24-difluoro-25-hydroxycholest-5-ene) was dissolved in anhydrous methylene chloride (5 ml), pyridine (2 ml) and acetic anhydride (2 ml) for 20 hours at room temperature. Stirred. After concentration under reduced pressure, the residue was separated and purified by silica gel column chromatography (40 g of SiO 2 ), and crude crystals were obtained from the portion eluted with benzene-ether (20:1). Yield 62mg. This was recrystallized from a mixed solvent of cyclohexane and n-hexane, and 3β-acetoxy-24,
24-difluorocholester-5-en-25-ol
Obtained 44mg.
m.p.;163〜164.5゜
n.m.r.(CDCl3,TMS);
5.38(1H,m,C―6),4.60(1H,m,C
―3),200(3H,S,C―30アセチル),
1.28(6H,S,C―26,C―27)
mass(m/e);
420(M―60),405(M―60―15),362,
312,299,255,213
i.r.(KBr);3400,1730cm-1
元素分析(C29H46O3F2);
計算値,C;72.46,H;9.65,F;7.90
実測値,C;72.50,H;9.70,F;7.77
実施例 2
30mgの上記実施例1の生成物を四塩化炭素2ml
に溶解し、加熱還流させ、16mgのN―ブロモサク
シニイミドを加え、アルゴン気流下で25分間加熱
還流した。室温まで冷却し、析出したイミドの結
晶をろ過して除きろ液を減圧下濃縮乾燥させた。
残渣を1〜2mlのキシレンに溶解し、アルゴン気
流中、還流しているキシレン1.5mlとS―コリジ
ン0.5mlの溶液中に滴下し、さらに15分間加熱還
流した。酢酸エチルで抽出し、常法により処理し
て得られる粗生成物をアセトン5mlに溶解し、触
媒量のP―トルエンスルホン酸を加えて室温、ア
ルゴン下で15時間撹拌した。酢酸エチルより抽出
し、常法処理して得られる粗生成物を、プレパラ
テイブ薄層クロマトグラフイ(ベンゼン:酢酸エ
チル=15:1で3回展開)で精製し5mgの3β―
アセトキシ―24,24―ジフルオロコレスタ―5,
7―ジエン―25―オールを得た。 mp; 163-164.5゜ nmr (CDCl 3 , TMS); 5.38 (1H, m, C-6), 4.60 (1H, m, C
-3), 200 (3H, S, C-30 acetyl),
1.28 (6H, S, C-26, C-27) mass (m/e); 420 (M-60), 405 (M-60-15), 362,
312, 299, 255, 213 ir (KBr); 3400, 1730 cm -1 Elemental analysis (C 29 H 46 O 3 F 2 ); Calculated value, C; 72.46, H; 9.65, F; 7.90 Actual value, C; 72.50 , H; 9.70, F; 7.77 Example 2 30 mg of the product of Example 1 above was dissolved in 2 ml of carbon tetrachloride.
The mixture was heated to reflux, 16 mg of N-bromosuccinimide was added, and the mixture was heated to reflux for 25 minutes under an argon atmosphere. The mixture was cooled to room temperature, the precipitated imide crystals were removed by filtration, and the filtrate was concentrated and dried under reduced pressure.
The residue was dissolved in 1 to 2 ml of xylene and added dropwise to a solution of 1.5 ml of xylene and 0.5 ml of S-collidine that was being refluxed in an argon atmosphere, and the solution was further heated under reflux for 15 minutes. The crude product obtained by extraction with ethyl acetate and treatment in a conventional manner was dissolved in 5 ml of acetone, a catalytic amount of P-toluenesulfonic acid was added, and the mixture was stirred at room temperature under argon for 15 hours. The crude product obtained by extraction with ethyl acetate and conventional treatment was purified by preparative thin layer chromatography (developed three times with benzene:ethyl acetate = 15:1) to obtain 5 mg of 3β-
Acetoxy-24,24-difluorocholester-5,
7-diene-25-ol was obtained.
UV(λエタノールnax);263,272,282,292nm
mass(m/e);
419(M―(―C(CH3)2OH)),418(M―
60),403(M―60―15),313(M―側鎖),
253(313−60)
参考例 2
3mgの3β―アセトキシ―24,24―ジフルオロ
コレスタ―5,7―ジエン―25―オールの3mg
を、アルゴンでバブルしたテトラヒドロフラン5
mlに溶解した。これにアルゴンでバブルした5%
水酸化カリウム―メタノール溶液5mlを加え、ア
ルゴン下で15時間放置した。酢酸エチルで抽出
し、常法処理して得られる生成物を40mlのエタノ
ールと90mlのベンゼンに溶解し、アルゴンガスを
バブルしながら、氷冷下に紫外線(ハノビア
654A36,200W)を2.5時間照射した。アルゴン
気流中で1時間還流したのち、減圧下溶媒を除去
し得られる粗生成物をプレパラテイブ薄層クロマ
トグラフイー(ベンゼン:酢酸エチル=5:1で
3回展開)で精製し、0.76gの生成物を得、これ
を更に高速液体クロマトグラフイー(HPLC:
Zorbax SiL,CH2Cl2)により精製し、0.2mgの
24,24―ジフルオロ―25―ヒドロキシビタミン
D3を得た。 UV ( λethanolnax ); 263, 272, 282, 292nm mass (m/e); 419 (M-(-C( CH3 ) 2OH )), 418(M-
60), 403 (M-60-15), 313 (M-side chain),
253 (313-60) Reference Example 2 3 mg of 3β-acetoxy-24,24-difluorocholester-5,7-dien-25-ol
and tetrahydrofuran bubbled with argon 5
Dissolved in ml. This was bubbled with 5% argon.
5 ml of potassium hydroxide-methanol solution was added and left under argon for 15 hours. The product obtained by extraction with ethyl acetate and conventional treatment was dissolved in 40 ml of ethanol and 90 ml of benzene, and while bubbling argon gas, the product was exposed to ultraviolet light (Hanovia) while cooling on ice.
654A36, 200W) was irradiated for 2.5 hours. After refluxing for 1 hour in an argon stream, the solvent was removed under reduced pressure, and the resulting crude product was purified by preparative thin layer chromatography (developed 3 times with benzene:ethyl acetate = 5:1) to yield 0.76 g. This is further processed by high performance liquid chromatography (HPLC).
Purified by Zorbax SiL, CH 2 Cl 2 ), 0.2 mg of
24,24-difluoro-25-hydroxyvitamin
Got D3 .
UV(エタノール);λnax=228nm
λnio=264nm
mass(m/e);436(M+),421(M―15),
418(M―18),403(M―15―18),
377,271,253,136,118 UV (ethanol); λ nax = 228 nm λ nio = 264 nm mass (m/e); 436 (M + ), 421 (M-15),
418 (M-18), 403 (M-15-18),
377, 271, 253, 136, 118
Claims (1)
る。また〓は、単結合もしくは二重結合を表わ
す。〕 で表わされる24,24―ジフルオロ―25―ヒドロキ
シコレステン類。[Claims] 1. The following formula [] [In the formula, R is a hydrogen atom or a hydroxyl group-protecting group. Also, 〓 represents a single bond or a double bond. ] 24,24-difluoro-25-hydroxycholestenes represented by.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14902878A JPS5576899A (en) | 1978-12-04 | 1978-12-04 | 24,24-difluoro-25-hydroxycholestene derivative or its hydroxy-protected derivative and its preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14902878A JPS5576899A (en) | 1978-12-04 | 1978-12-04 | 24,24-difluoro-25-hydroxycholestene derivative or its hydroxy-protected derivative and its preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5576899A JPS5576899A (en) | 1980-06-10 |
JPS6244558B2 true JPS6244558B2 (en) | 1987-09-21 |
Family
ID=15466084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14902878A Granted JPS5576899A (en) | 1978-12-04 | 1978-12-04 | 24,24-difluoro-25-hydroxycholestene derivative or its hydroxy-protected derivative and its preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5576899A (en) |
-
1978
- 1978-12-04 JP JP14902878A patent/JPS5576899A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5576899A (en) | 1980-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5854160B2 (en) | Method for producing 1α,3β-dihydroxysteroid-5-ene or its derivative | |
EP3965773A1 (en) | Novel method for synthesizing 25-oh cholesterol/calcifediol from phytosterol | |
CN115884978A (en) | Process for preparing cholic acid derivatives and starting materials therefor | |
US20220372065A1 (en) | Synthesis of cholesterol and vitamin d3 from phytosterols | |
US3862972A (en) | Process for preparing Unsaturated Carboxylic Acids | |
JPS6129360B2 (en) | ||
WO2001064701A1 (en) | Process for preparing flavonoids | |
TWI710550B (en) | Process for the preparation of lubiprostone and intermediates thereof | |
Marshall et al. | A new direct synthesis of equilin from equilenin. Potassium–ammonia reduction of some non-conjugated double bonds | |
JP2752366B2 (en) | Process for the preparation of 17α-ethynyl-17β-hydroxy-18-methyl-4,15-estradien-3-one and intermediate products of this process | |
JPS6244558B2 (en) | ||
US5182393A (en) | Process for precursors to calcitriol and related compounds | |
US4298537A (en) | Process for producing steroid compounds having an oxo group in the side chain | |
JPS6148499B2 (en) | ||
JPS6157836B2 (en) | ||
GB2190085A (en) | Intermediates for 1,23-dihydroxyvitamin d compounds | |
JPS6310720B2 (en) | ||
US5225569A (en) | Process for precursors to calcitriol and related compounds | |
JPS6148498B2 (en) | ||
JPS6258351B2 (en) | ||
JP2975704B2 (en) | Steroid derivatives | |
JPS623840B2 (en) | ||
JP2975705B2 (en) | Steroid derivatives | |
JPS6148500B2 (en) | ||
JP3228486B2 (en) | Hydroxyketone derivative and method for producing the same |